Biotechnology
Medical
Biopharmaceutical
Alnylam Pharmaceuticals
$80.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$80.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.32 (2.96%) Today
$0.00 (0.00%) As of 4:08 PM EDT after-hours
Why Robinhood?
You can buy or sell ALNY and other stocks, options, ETFs, and crypto commission-free!
About ALNY
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. Read More The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Employees
1,065
Headquarters
Cambridge, Massachusetts
Founded
2002
Market Cap
8.97B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
856.61K
High Today
$81.01
Low Today
$78.77
Open Price
$78.77
Volume
481.27K
52 Week High
$124.22
52 Week Low
$60.27
Collections
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Therapy
Technology
US
Price Paid on Robinhood
13% Lower
Right Now
52 Week Low
$60.27
Average Price Paid
$92.47
52 Week High
$124.22
Analyst Ratings
79%
of 19 ratings
Buy
79%
Hold
16%
Sell
5%
ALNY Earnings
-$2.28
-$1.92
-$1.56
-$1.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$1.86 per share
Actual
-$1.83 per share